Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | ESR1 | P03372 | 1/20 | 0.61 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.61 |
| ▸ | LTA4H | P09960 | 6/20 | 0.56 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.52 |
| ▸ | BAX | Q07812 | 1/20 | 0.52 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.44 |
| ▸ | TAAR5 | O14804 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | PCNA | P12004 | 1/20 | 0.42 |
| ▸ | TTR | P02766 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24413531 | 0.92 | MEN1 (0.52) | MEN1KMT2AESR1ESR2LTA4H | |
| SCHEMBL9296009 | 0.83 | PPARG (0.40) | MEN1KMT2AESR1ESR2LTA4H | |
| SCHEMBL16551547 | 0.81 | MEN1 (0.82) | MEN1KMT2AESR1ESR2LTA4H | |
| SCHEMBL14616574 | 0.81 | THRB (0.49) | MEN1KMT2APCNATTR | |
| SCHEMBL14575487 | 0.81 | MEN1 (0.58) | MEN1KMT2AESR1ESR2LTA4H | |
| SCHEMBL22311203 | 0.80 | PPARG (0.45) | MEN1KMT2AESR1LTA4HTAAR5 | |
| SCHEMBL24414010 | 0.80 | MEN1 (0.64) | MEN1KMT2AESR1ESR2LTA4H | |
| SCHEMBL24407708 | 0.79 | PARP15 (0.55) | MEN1KMT2APARP10TTR | |
| SCHEMBL22311194 | 0.79 | ST14 (0.66) | MEN1KMT2ATAAR5TAAR1TTR | |
| SCHEMBL11096627 | 0.78 | MEN1 (0.61) | MEN1KMT2AESR1ESR2LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220146930-A1 | SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2022-05-12 | — | — | US | disclosed |
| US-20130017163-A1 | HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY | IPE, INC. | 2013-01-17 | — | — | US | disclosed |
| US-20130017163-A1 | HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY | IPE, INC. | 2013-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220146930-A1 | SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | RER1, FGFR1, NHERF1 | MEN1 2209/4885KMT2A 1914/4885ESR1 662/4885 |
| US-20130017163-A1 | HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY | TYR, PRDX5, PPARG | MEN1 4824/4885KMT2A 3626/4885ESR1 211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.